Treatment of myoclonus-dystonia syndrome with tetrabenazine.
暂无分享,去创建一个
[1] J. Rothwell,et al. The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias. , 2014, JAMA neurology.
[2] M. LeDoux,et al. Incomplete nonsense‐mediated decay facilitates detection of a multi‐exonic deletion mutation in SGCE , 2013, Clinical genetics.
[3] Nageswara Rao Pilli,et al. Liquid chromatography-tandem mass spectrometric assay for the determination of tetrabenazine and its active metabolites in human plasma: a pharmacokinetic study. , 2013, Biomedical chromatography : BMC.
[4] Andreea C. Bostan,et al. Cerebellar networks with the cerebral cortex and basal ganglia , 2013, Trends in Cognitive Sciences.
[5] Anand I. Rughani,et al. Surgical treatment of myoclonus dystonia syndrome , 2013, Movement disorders : official journal of the Movement Disorder Society.
[6] V. Dhawan,et al. Metabolic changes in DYT11 myoclonus-dystonia , 2013, Neurology.
[7] F. Baas,et al. SGCE isoform characterization and expression in human brain: implications for myoclonus–dystonia pathogenesis? , 2011, European Journal of Human Genetics.
[8] N. Nardocci,et al. Myoclonus–dystonia syndrome: Clinical presentation, disease course, and genetic features in 11 families , 2008, Movement disorders : official journal of the Movement Disorder Society.
[9] J. Jankovic,et al. Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders , 2007, Movement disorders : official journal of the Movement Disorder Society.
[10] Yuqing Li,et al. Myoclonus, Motor Deficits, Alterations in Emotional Responses and Monoamine Metabolism in ε-Sarcoglycan Deficient Mice , 2006 .
[11] J. Jankovic,et al. Long-term effects of tetrabenazine in hyperkinetic movement disorders , 1997, Neurology.
[12] P. Levitt,et al. Central adrenergic receptor changes in the inherited noradrenergic hyperinnervated mutant mouse tottering , 1987, Brain Research.
[13] J. Lorden,et al. Alterations in the noradrenergic projection to the cerebellum of the dystonic (dt) rat , 1986, Brain Research.
[14] G. Kirov,et al. SGCE mutations cause psychiatric disorders: clinical and genetic characterization. , 2013, Brain : a journal of neurology.
[15] Yuqing Li,et al. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. , 2006, Journal of biochemistry.
[16] M. Hallett,et al. The Unified Myoclonus Rating Scale. , 2002, Advances in neurology.